MG
CLX icon

Michael Gelband’s Clorox CLX Stock Holding History

Michael Gelband’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-75,132
Closed -$11.1M – 1532
2025
Q1 		$11.1M Sell
75,132
-623,768
-89% -$95.3M 0.11% 182
2024
Q4 		$114M Buy
698,900
+456,114
+188% +$74.6M 0.78% 11
2024
Q3 		$39.6M Buy
242,786
+174,832
+257% +$25.9M 0.24% 62
2024
Q2 		$9.27M Sell
67,954
-264,519
-80% -$36.7M 0.06% 266
2024
Q1 		$50.9M Buy
332,473
+39,827
+14% +$5.95M 0.39% 37
2023
Q4 		$41.7M Buy
292,646
+247,522
+549% +$33M 0.27% 43
2023
Q3 		$5.91M Sell
45,124
-14,289
-24% -$2.17M 0.06% 335
2023
Q2 		$9.45M Sell
59,413
-122,585
-67% -$19.8M 0.08% 266
2023
Q1 		$28.8M Buy
181,998
+129,601
+247% +$19.4M 0.24% 61
2022
Q4 		$7.35M Buy
52,397
+32,946
+169% +$4.68M 0.11% 248
2022
Q3 		$2.5M Sell
19,451
-4,800
-20% -$693K 0.03% 692
2022
Q2 		$3.42M Buy
+24,251
New +$3.46M 0.04% 552
2022
Q1 		– Sell
-92,306
Closed -$16.1M – 2245
2021
Q4 		$16.1M Buy
92,306
+89,181
+2,854% +$14.9M 0.17% 107
2021
Q3 		$518K Buy
3,125
+859
+38% +$148K 0.01% 1354
2021
Q2 		$408K Sell
2,266
-12,414
-85% -$2.27M ﹤0.01% 1554
2021
Q1 		$2.83M Buy
14,680
+7,923
+117% +$1.53M 0.04% 444
2020
Q4 		$1.36M Buy
+6,757
New +$1.4M 0.01% 702
2019
Q4 		– Sell
-5,300
Closed -$805K – 1571
2019
Q3 		$805K Buy
+5,300
New +$838K 0.03% 462
2019
Q2 		– Sell
-3,084
Closed -$495K – 1126
2019
Q1 		$495K Buy
+3,084
New +$478K 0.04% 341

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Michael Gelband's CLX Position: Q2 2025 in Review

Michael Gelband sold out of Clorox (CLX) in Q2 2025, closing a stake of 75,132 shares — an estimated $11.1M sold.

Michael Gelband first reported a position in CLX in Q1 2019 and held it in 19 quarters. The position peaked at $114M in Q4 2024. 1,126 funds tracked by Wall St. Rank hold CLX as of Q2 2025.

  • Michael Gelband reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
  • Michael Gelband sold 75,132 Clorox shares in Q2 2025, an estimated $11.1M.
  • Michael Gelband first reported a position in Clorox in Q1 2019 and held it in 19 quarters.
  • Michael Gelband's Clorox position peaked at $114M in Q4 2024.
  • 1,126 funds tracked by Wall St. Rank held Clorox as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.